Pralatrexate
http://dbpedia.org/resource/Pralatrexate an entity of type: Thing
Pralatrexate, sold under the brand name Folotyn, is a medication used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Pralatrexate was approved for medical use in the United States in September 2009, as the first treatment for Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma.
rdf:langString
rdf:langString
Pralatrexate
xsd:integer
1300596
xsd:integer
1123038028
rdf:langString
BA05
rdf:langString
L01
xsd:integer
23
xsd:integer
146464
xsd:integer
71223
xsd:integer
1201746
xsd:integer
130578
rdf:langString
DB06813
xsd:integer
23
rdf:langString
Pralatrexate ball-and-stick.png
rdf:langString
N--(L)-glutamic acid
rdf:langString
D05589
rdf:langString
Rx-only
xsd:integer
7
xsd:integer
5
xsd:integer
148121
rdf:langString
O=C[C@@H]CCCO
xsd:integer
1
rdf:langString
OGSBUKJUDHAQEA-WMCAAGNKSA-N
rdf:langString
Folotyn
rdf:langString
A8Q8I19Q20
rdf:langString
changed
xsd:integer
461750802
xsd:integer
300
rdf:langString
Pralatrexate, sold under the brand name Folotyn, is a medication used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Pralatrexate was approved for medical use in the United States in September 2009, as the first treatment for Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma.
xsd:integer
6840
rdf:langString
Rx-only
rdf:langString
Pralatrexate
xsd:nonNegativeInteger
8727
rdf:langString
Folotyn
xsd:string
146464-95-1
xsd:string
71223
xsd:string
1201746
xsd:string
DB06813
xsd:string
A8Q8I19Q20
xsd:string
D05589
xsd:string
148121